Quick Read
An asthma exacerbation is not simply “more wheeze”. It is an acute or sub-acute worsening of symptoms and airflow limitation, and severe attacks can progress to respiratory failure even when the chest becomes quieter rather than noisier.
The distinct Medicine Web job is: worsening breathlessness/wheeze/cough/chest tightness → severity assessment using symptoms, respiratory rate, oxygenation and lung function where possible → rapid bronchodilation + oxygen when needed → early systemic corticosteroid for moderate/severe attacks → add ipratropium or intravenous magnesium in selected severe states → reassess response → transfer/ICU/ventilation if deterioration persists → restore ICS-containing controller treatment → inhaler/action-plan review → recurrence prevention and human return.
Wait, What? A “Silent Chest” Can Be More Dangerous Than Loud Wheezing
GINA 2026 identifies drowsiness, confusion and a silent chest as signs requiring immediate escalation to intensive care. When airflow becomes critically low, there may be too little air movement to generate obvious wheeze.
Anti-collapse rules: wheeze ≠ severity; no wheeze ≠ improvement; oxygen saturation improved ≠ airflow obstruction resolved; bronchodilator given ≠ attack controlled; one exacerbation ≠ chronic asthma control acceptable; antibiotics ≠ routine asthma treatment.
The Acute Asthma Tube
Worsening symptoms → severity/airflow assessment → reliever bronchodilation ± oxygen → systemic steroid for significant exacerbation → ipratropium/magnesium selected escalation → repeat symptoms/O2/PEF receipt → severe/refractory route to acute care or ICU → ventilation support if failing → discharge controller/action plan → early follow-up → trigger and long-term control correction.
1. The Owner Is Acute Airflow-Obstruction Failure
The Respiratory Medicine Web owns chronic asthma and lung disease broadly. This node owns the acute trajectory when reversible bronchoconstriction, inflammation and mucus create time-sensitive airflow failure.
2. Severity Is Measured From Function, Not Noise
GINA 2026 recommends assessing dyspnoea, respiratory rate, oxygen saturation and objective airflow limitation such as peak expiratory flow where feasible while treatment begins.
3. Bronchodilation Is the First Mechanical Move
Rapid-acting inhaled bronchodilator therapy relaxes airway smooth muscle and is central to acute treatment. Response should be measured rather than inferred from administration.
RFE rule: medicine delivered ≠ airway reopened.
4. Oxygen Treats Hypoxaemia, Not Bronchospasm
Controlled oxygen is used when oxygenation is inadequate, but it does not relieve the underlying airway narrowing. The state must preserve both oxygenation and airflow.
5. Systemic Corticosteroids Address the Inflammatory Component
GINA recommends early systemic corticosteroids for moderate or severe exacerbations because bronchodilation alone does not rapidly suppress the inflammatory process driving relapse.
6. Ipratropium Is an Add-On in More Severe Attacks
For moderate or severe presentations, short-acting anticholinergic bronchodilation can be added to the initial reliever pathway. It is an adjunct rather than a replacement for primary bronchodilator treatment.
7. Intravenous Magnesium Is a Selected Rescue Adjunct
GINA 2026 advises considering intravenous magnesium sulfate when severe exacerbation does not respond adequately to initial treatment. It is not routine treatment for every mild attack.
8. Anaphylaxis Changes the First Drug
GINA explicitly states that if asthma symptoms occur with features of anaphylaxis, epinephrine/adrenaline should be given first. The Anaphylaxis & Severe Allergic Emergency Web owns that systemic allergic state.
9. Drowsiness or Confusion Signals Respiratory Failure Risk
Altered mental state can reflect exhaustion, hypercapnia or severe hypoxaemia and should trigger immediate escalation. Waiting for a dramatic saturation fall can be unsafe.
10. Ventilation Is a Rescue State, Not a Routine Asthma Destination
Patients with impending respiratory arrest may require invasive ventilatory support. Mechanical ventilation in severe asthma has distinctive risks because air trapping and dynamic hyperinflation can impair circulation and worsen barotrauma.
11. Chest X-Ray and Antibiotics Are Not Routine
GINA 2026 advises against routine chest X-ray and routine antibiotics for uncomplicated asthma exacerbations. Imaging or antibiotics should answer a competing diagnosis or complication question rather than become automatic.
12. Discharge Is an Active Treatment Phase
GINA recommends starting or continuing ICS-containing therapy before discharge, reviewing inhaler technique, reducing reliever use back toward appropriate as-needed patterns and providing a written asthma action plan.
13. The Attack Is a Report Card on Long-Term Control
A severe exacerbation asks whether controller therapy is adequate, inhaler technique works, adherence/access is realistic, smoking or allergen exposure persists, occupational triggers exist, or the diagnosis needs re-evaluation.
14. Evidence, Uncertainty and Correction
GINA 2026 is the current global strategy and explicitly treats acute asthma as a dynamic response problem. The correction loop is severity estimate → immediate treatment → one-hour-or-earlier clinical/oxygen/airflow receipt → escalate or de-escalate → identify trigger and chronic-control failure → action plan and follow-up.
15. RFE: Did the Airway Reopen, and Did We Reduce the Chance It Closes Again?
The Medicine RFE asks whether timely, evidence-grounded and ethically authorised help reaches the human and improves outcomes without preventable harm. In acute asthma, success means dangerous airflow limitation was recognised, therapy restored breathing without delaying escalation, unnecessary antibiotics/testing were avoided, and the person left with controller treatment, correct inhaler technique and an action plan capable of changing the next trajectory.
eduKateAI Acute Asthma Tube Card
- TRIGGER: infection, allergen, smoke, exercise, adherence/access, occupational or unknown?
- SEVERITY: dyspnoea, respiratory rate, oxygen saturation and PEF?
- RED FLAGS: silent chest, exhaustion, drowsiness or confusion?
- BRONCHODILATOR: delivered and objective response?
- OXYGEN: needed and response?
- STEROID: significant exacerbation requiring systemic therapy?
- ADJUNCTS: ipratropium or magnesium indicated?
- ALTERNATIVE: anaphylaxis, pneumonia, PE, pneumothorax or other?
- ESCALATION: hospital, ICU or ventilation route?
- RETURN: ICS-containing controller, inhaler technique, written action plan and follow-up?
Canonical External Source
Global Initiative for Asthma — 2026 Strategy Report
Educational boundary: Severe asthma attacks can become life-threatening. This page explains information architecture and does not prescribe individual inhaler or steroid doses, determine ventilation thresholds or replace urgent medical assessment.